Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000

British Journal of Surgery

Volumn 94, Issue 9, 2007, Pages 1162-1171

  Fitzsimmons, D ^a   Osmond, C ^b   George, S ^b   Johnson, C D ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; HUMAN; ONSET AGE; PANCREAS CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH CANCER; UNITED KINGDOM; ADULT; AGE DISTRIBUTION; AGED; COHORT ANALYSIS; FEMALE; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; POISSON DISTRIBUTION; RISK FACTOR; SEX RATIO; STOMACH TUMOR;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; ENGLAND; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POISSON DISTRIBUTION; RISK FACTORS; SEX DISTRIBUTION; STOMACH NEOPLASMS; WALES;

EID: 35448963508     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5751     Document Type: Article

References (47)

1. Office for National Statistics. Mortality Statistics: Cause. Review of the Registrar General on Deaths by Cause, Sex and Age, in England and Wales, 2003. Series DH2 no. 30. Office for National Statistics: London, 2004.
2. Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 1998; 34: 2167-2175.
3. Faivre J, Forman D, Esteve J, Obradovic M, Sant M. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer 1998; 34: 2184-2190.
4. La Vecchia C, Negri E, Levi F, Decarli A, Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998; 34: 118-141.
5. Newnham A, Quinn MJ, Babb P, Kang JY, Majeed A. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Aliment Pharmacol Ther 2003; 17: 665-676.
6. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82: 111-115.
7. Quinn M. Cancer Trends in England and Wales, 1950-1999. Stationery Office: London, 2001.
8. Swerdlow A, dos Santos Silva I, Doll R. Cancer Incidence and Mortality in England and Wales: Trends and Risk Factors. Oxford University Press: Oxford, 2001.
9. Office for National Statistics. 20th Century Mortality (England & Wales 1901-2000). CD-ROM. Office for National Statistics: London, 2005.
10. Office for National Statistics. Cancer Registrations, Annual Reports, 1971-2003. Office for National Statistics: London, 2006.
11. Gordis L. Epidemiology (3rd edn). Elsevier Saunders: Philadelphia, 2004.
12. O'Callaghan FJ, Osmond C, Martyn CN. Trends in epilepsy mortality in England and Wales and the United States, 1950-1994. Am J Epidemiol 2000; 151: 182-189.
13. Osmond C. Using age, period and cohort models to estimate future mortality rates. Int J Epidemiol 1985; 14: 124-129.
14. Laheij RJ, Straatman H, Verbeek AL, Jansen JB. Mortality trend from cancer of the gastric cardia in The Netherlands, 1969-1994. Int J Epidemiol 1999; 28: 391-395.
15. Lambert R, Guilloux A, Oshima A, Pompe-Kirn V, Bray F, Parkin M et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 2002; 97: 811-818.
16. Aragones N, Pollan M, Rodero I, Lopez-Abente G. Gastric cancer in the European Union (1968-1992): mortality trends and cohort effect. Ann Epidemiol 1997; 7: 294-303.
17. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-1362.
18. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362.
19. Ito M, Tanaka S, Kamada T, Haruma K, Chayama K. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol 2006; 12: 10-16.
20. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9.
21. Axon A. Helicobacter pylori: what do we still need to know? J Clin Gastroenterol 2006; 40: 15-19.
22. Iso N, Matsuhisa T, Shimizu K. Helicobacter pylori infection among patients visiting a clinic in Kasama City, Ibaraki Prefecture. J Nippon Med Sch 2005; 72: 341-354.
23. Rowland M, Daly L, Vaughan M, Higgins A, Bourke B, Drumm B. Age-specific incidence of Helicobacter pylori. Gastroenterology 2006; 130: 65-72.
24. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer 2005; 116: 963-971.
25. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 1997; 72: 565-573.
26. Corley DA, Kubo A. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst 2004; 96: 1383-1387.
27. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654.
28. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-1289.
29. Ahlgren JD. Epidemiology and risk factors in pancreatic cancer. Semin Oncol 1996; 23: 241-250.
30. Scarpa A, Di Pace C, Talamini G, Falconi M, Lemoine NR, Iacono C et al. Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis. Gut 2000; 46: 842-848.
31. Trede M. The surgical options. In Surgery of the Pancreas, Trede M, Carter DC (eds). Churchill Livingstone: Edinburgh, 1993; 433-442.
32. Bramhall S, Dunn JA, Neoptolemos JP. Epidemiology of pancreatic cancer. In The Pancreas, Beger HG, Warshaw AL, Buchler MW, Carr-Locke DL, Neoptolemos JP, Russell C et al. (eds), vol. 2. Blackwell Science: Oxford, 1998; 889-906.
33. Boyle P, Maisonneuve P, Bueno de Mesquita B, Ghadirian P, Howe GR, Zatonski W. Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer 1996; 67: 63-71.
34. Neugut AI, Ahsan H, Robinson E. Pancreas cancer as a second primary malignancy. A population-based study. Cancer 1995; 76: 589-592.
35. Osmond C. Trends in Cancer Mortality 1951-1980: Analyses by Period of Birth and Death. Office of Population Censuses and Surveys, HMSO: London, 1983.
36. Brennan P, Bray I. Recent trends and future directions for lung cancer mortality in Europe. Br J Cancer 2002; 87: 43-48.
37. Shibuya K, Inoue M, Lopez AD. Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int J Cancer 2005; 117: 476-485.
38. Simon B, Printz H. Epidemiological trends in pancreatic neoplasias. Dig Dis 2001; 19: 6-14.
39. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363: 1049-1057.
40. Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem 2005; 95: 649-656.
41. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437.
42. Neoptolemos JP, Russell RC, Bramhall S, Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 1997; 84: 1370-1376.
43. Bachmann MO, Alderson D, Peters TJ, Bedford C, Edwards D, Wotton S et al. Influence of specialization on the management and outcome of patients with pancreatic cancer. Br J Surg 2003; 90: 171-177.
44. Burris HA III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-2413.
45. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210.
46. Berrino F, Capocaccia R, Esteve J, Gatta G, Hakulinen T, Micheli A et al. (eds). Survival of Cancer Patients in Europe: the EUROCARE-2 Study. IARC Scientific Publications no. 151. IARC Publications: Lyons, 1999.
47. Lenfant C, Friedman L, Thom T. Fifty years of death certificates: the Framingham Heart Study. Ann Intern Med 1998; 129: 1066-1067.